Clinical trial
Enteral Glutamine in Neurologically-injured Patients
NCT00204971 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00204971 |
|---|---|
| Title | Enteral Glutamine in Neurologically-injured Patients |
| Official title | Randomized, Placebo-controlled Clinical Trial of Enteral Glutamine Supplementation in Neurologically-injured Patients |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neurologic Injury, Traumatic Brain Injury |
| Intervention type | Dietary Supplement, Other |
| Interventions | Enteral glutamine powder, placebo |
| Enrollment | 102 |
| Start date | Jan 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: